From January 22, 2024 to March 31, 2024, the company has repurchased 25,705,695 shares, representing 1% for CNY 119.53 million. With this, the company has completed the repurchase of 25,705,695 shares, representing 1% for CNY 119.53 million under the buyback announced on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.48 CNY | +5.79% | +8.09% | +8.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.51% | 192.78Cr | |
+21.28% | 4.44TCr | |
+24.60% | 2.3TCr | |
+17.89% | 1.51TCr | |
+12.87% | 1.31TCr | |
+44.67% | 1.19TCr | |
-8.33% | 698.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+12.22% | 551.54Cr |
- Stock Market
- Equities
- 600572 Stock
- News Zhejiang CONBA Pharmaceutical Co.,Ltd.
- Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.